Are the Available Data Sufficient to Recommend Widespread Use of TTVI in Symptomatic Severe TR Patients? NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Original Broadcast: June 26, 2025

Conference: NY Valves 2025